Published on
December 13, 2016
- 00:09 GMT
BioSyent Announces Sale of Shares
TORONTO, ONTARIO--(Marketwired - Dec 12, 2016) - BioSyent Inc. ("BioSyent", "the company") (TSX VENTURE:RX) President & CEO René Goehrum has advised the company that he has sold 300,000 shares in a single block to an existing …
Distribution channels:
Healthcare & Pharmaceuticals Industry
